83. Zeiger, R.S., Mellon, M., Chipps, B.E., Murphy, K.R. Schatz, M., Kosinski,
M., Lampl, K., and Ramachandran, S. Test for Respiratory and Asthma
Control in Kids (TRACK™): Clinically Meaningful Changes in Score. J
Allergy Clin Immunol 2011 ( In Press).

82. Chipps, B.E. Letter to the Editor Spirometry Versus Flow Volume
Inspiratory and Expiratory Loop. Annals of Allergy, Asthma, &
Immunology 2011; 107(2): 183. View

81. Chipps, B.E. Letter to the Editor Treatment of Acute Asthma. Journal of Asthma 2011 View

80. Chipps, B.E. Letter to the Editor Novel Epinephrine Auto-Injector ( NEA):
Sharps Injury Prevention Validation and Comparable Analysis with
Epipen and Twinject. Annals of Allergy, Asthma, & Immunology 2011;
107(3): 286 View

79. Haselkorn, T., Szefler, S.J., Zeiger, R.S., Chipps, B.E., Fish, J., Kamath, T., Mink, D., and Yegin, A. Economic Burden of Impairment in Children with Severe or Difficult-to-Treat Asthma. Annals of Allergy, Asthma & Immunology 2011 View

78. Arellano, F.M., Arana, A., Wentwort, C.E., Vidaurre, C.F., and Chipps,B.E.
Prescription Patterns for Asthma Medications in Children and Adolescents in the United States. Pediatric Allergy & Immunology 2011 View

77. Chipps, B.E., Spector, S., Farrar, J., Carr, W., Meltzer, E., Storms, W., Kaliner, M., Luskin, A., Bukstein, D., Oppenheimer, J., Smart, B., Derebery, J., Harder, J., Dykewicz, M., and Benniger, M. Letter to the Editor Differences in Recommendations Between the Allergic Rhinitis and Its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters. J Allergy Clin Immunol (127)6, 1640-1641.e1. View

***Updated 1/13/2021***


COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.


Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

Within the health care community as a whole, there has been an overall increase in the number of patients not seeking necessary medical treatment due to concerns about COVID-19.

If you have a medical problem, please contact your health care provider. It’s important not to delay seeking treatment when you need it.

We are currently open for in-office visits and will continue to offer telemedicine visits moving forward. We understand you might have concerns about coming in to see your health care provider. We want you to know about the steps we are taking to ensure your safety and help prevent the spread of infection:

o Mandatory Masking – All patients and visitors must be masked while in any of our care sites. Please wear a mask or face covering when you enter our facility.

o Limiting Individuals at Appointments – We will limit who is present at a patient visit. Only the patient will be allowed into the facility. If the patient is a minor, only one parent/guardian will be allowed to accompany the patient.

o Temperature Checks – All patients (and parent/guardian if patient is a minor) will have their temperatures checked at the door. Anyone with a temperature of 100 degrees or higher will be asked to reschedule their appointment or conduct the appointment via telemedicine.

o Employee Screening – We’ve instituted mandatory employee temperature screenings before each shift.

New Injection Hours – Effective 7/6/2020

Folsom Office
Monday 8:00-11:45 / 1-4:45
Tuesday Closed
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-4:45
Friday 8:00-11:45 / 1-4:45

Roseville Office
Monday 9:00-11:45 / 1-4:45
Tuesday 8:00-11:45 / 1-4:45
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-5:45
Friday 8:00-11:45 / 1-4:45

Monday 9:00-4:45
Tuesday 8:00-5:45
Wednesday 8:00-4:45
Thursday 9:00-4:45
Friday 8:00-4:45